Literature DB >> 1486969

Protective effect of pulmonary surfactant on elastase-induced emphysema in mice.

C J Otto-Verberne1, A A Ten Have-Opbroek, C Franken, J Hermans, J H Dijkman.   

Abstract

The aim of this study was to obtain some evidence of a protective role for pulmonary surfactant in the pathogenesis of emphysema. Firstly, we developed a quick and easy method to treat mice with a series of intratracheal instillations. Subsequently, three groups of mice were treated as follows: two groups received intratracheal instillations with pancreatic elastase (1.8 mg.kg-1 BW) followed after 3, 48 and 96 h in one group (El/Surf group) by intratracheal administration of surfactant (100 mg phospholipid.kg-1 BW), and in the other group by instillations with saline (El/s group). The third group of control mice was treated with saline followed by three doses of surfactant (s/Surf group). After eight weeks, the mice were killed and emphysema was measured by calculating the mean linear intercepts (Lm) of airspaces. The Lm values in the different groups were statistically tested for differences by the Mann-Whitney test. Instillation of pancreatic elastase (El/s group) resulted in an evenly distributed increase in Lm compared with the control group. Administration of surfactant in elastase-treated mice (El/Surf group) resulted in a statistically significant inhibition of airspace enlargement. Although the Lm in the El/Surf group was still higher than in the control group, analysis of histograms of Lm values per field of examination revealed that the Lm distribution in the former group was similar to that of the s/Surf group. The El/s group, on the contrary, showed the presence of many fields with enlarged air spaces. Repeated instillations with saline and/or surfactant had no effect on the Lm.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486969

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Protection of human respiratory epithelium from Pseudomonas aeruginosa adherence by phosphatidylglycerol liposomes.

Authors:  S Girod de Bentzmann; O Bajolet-Laudinat; F Dupuit; D Pierrot; C Fuchey; M C Plotkowski; E Puchelle
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

2.  Diminished ICAM-1 expression and impaired pulmonary clearance of nontypeable Haemophilus influenzae in a mouse model of chronic obstructive pulmonary disease/emphysema.

Authors:  Bing Pang; Wenzhou Hong; Shayla L West-Barnette; Nancy D Kock; W Edward Swords
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

3.  Maternal smoking and the retinoid pathway in the developing lung.

Authors:  Sara E Manoli; Lacey A Smith; Carrie A Vyhlidal; Chang Hyeok An; Yolanda Porrata; Wellington V Cardoso; Rebecca M Baron; Kathleen J Haley
Journal:  Respir Res       Date:  2012-06-01

4.  Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction.

Authors:  Helen Ilumets; Witold Mazur; Tuula Toljamo; Noora Louhelainen; Pentti Nieminen; Hideo Kobayashi; Nobuhisa Ishikawa; Vuokko L Kinnula
Journal:  BMC Pulm Med       Date:  2011-04-19       Impact factor: 3.317

Review 5.  Neutrophilic Inflammation in the Immune Responses of Chronic Obstructive Pulmonary Disease: Lessons from Animal Models.

Authors:  Gang Huang; Xu-Chen Xu; Jie-Sen Zhou; Zhou-Yang Li; Hai-Pin Chen; Yong Wang; Wen Li; Hua-Hao Shen; Zhi-Hua Chen
Journal:  J Immunol Res       Date:  2017-04-23       Impact factor: 4.818

6.  Pelvic Organ Support in Animals with Partial Loss of Fibulin-5 in the Vaginal Wall.

Authors:  Kathleen Chin; Cecilia Wieslander; Haolin Shi; Sunil Balgobin; T Ignacio Montoya; Hiromi Yanagisawa; R Ann Word
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

7.  Surfactant protein A expression and distribution in human lung samples from smokers with or without chronic obstructive pulmonary disease in China.

Authors:  Zhizhen Liu; Siyang Chen; Yongjian Xu; Xiansheng Liu; Pian Xiong; Yu Fu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.